Staphylococcus aureus:: The new adventures of a legendary pathogen

被引：25

作者：

Rehm, Susan J. ^{[1
]}

机构：

[1] Cleveland Clin, Dept Infect Dis, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2008年 / 75卷 / 03期

关键词：

D O I：

10.3949/ccjm.75.3.177

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nosocomial infections with strains of methicillin-resistant Staphylococcus aureus (MRSA) began to emerge in the 1960s, are increasing in frequency, and tend to have worse outcomes than infections due to methicillin-susceptible S. aureus. Community-associated MRSA infections emerged in the 1990s. Community-associated MRSA strains have up to now been epidemiologically and bacteriologically distinct from hospital-associated MRSA strains, but in a new twist, MRSA strains that have so far been only community-associated are invading the hospital. Another worrisome trend is increasing resistance to vancomycin (Vancocin).

引用

页码：177 / +

页数：11

共 52 条

[1] Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria [J].

Appelbaum, PC ;

Jacobs, MR .

CURRENT OPINION IN MICROBIOLOGY, 2005, 8 (05) :510-517

[2]

Baddour, 2005, CIRCULATION, V112, P2373, DOI 10.1161/CIRCULATIONHA.105.167942

[3]

Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564

[4] STAPHYLOCOCCUS-AUREUS BACTEREMIA - CLINICAL, SEROLOGIC, AND ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH AND WITHOUT ENDOCARDITIS [J].

BAYER, AS ;

LAM, K ;

GINZTON, L ;

NORMAN, DC ;

CHIU, CY ;

WARD, JI .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :457-462

[5] Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients [J].

Bishop, E ;

Melvani, S ;

Howden, BP ;

Charles, PGP ;

Grayson, ML .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1599-1602

[6] Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus [J].

Blot, SI ;

Vandewoude, KH ;

Hoste, EA ;

Colardyn, FA .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2229-2235

[7] Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus [J].

Boucher, Helen W. ;

Sakoulas, George .

CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) :601-608

[8] STAPHYLOCOCCUS-AUREUS ENDOCARDITIS - CLINICAL MANIFESTATIONS IN ADDICTS AND NONADDICTS [J].

CHAMBERS, HF ;

KORZENIOWSKI, OM ;

SANDE, MA .

MEDICINE, 1983, 62 (03) :170-177

[9] Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].

Chang, FY ;

Peacock, JE ;

Musher, DM ;

Triplett, P ;

MacDonald, BB ;

Mylotte, JM ;

O'Donnell, A ;

Wagener, MM ;

Yu, VL .

MEDICINE, 2003, 82 (05) :333-339

[10] Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus [J].

Charles, PGP ;

Ward, PB ;

Johnson, PDR ;

Howden, BP ;

Grayson, ML .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :448-451

← 1 2 3 4 5 6 →